vimarsana.com

Page 255 - சந்தைப்படுத்தல் தகவல்தொடர்புகள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

ITM Announces Poster Presentation Outlining the Ongoing Phase III GEP-NET Trial COMPETE at AACR Annual Meeting 2021

(1) ITM AG today announced that the company will present a poster describing the clinical trial design for its ongoing phase III trial COMPETE for their lead candidate, no-carrier-added Lutetium-177-Edotreotide (n.c.a. 177Lu-Edotreotide), a Targeted Radionuclide Therapy for gastroenteropancreatic neuroendocrine tumors (GEP-NETs), at the upcoming American Association of Cancer Research (AACR) Virtual Annual Meeting on April 10-15, 2021 and May 17-21, 2021. The e-poster website will be launched on Saturday, April 10, 2021 at 8.30am ET and will remain available for viewing until Monday, June 21, 2021. Please see below for details on the poster abstract. Session Category: Phase III Clinical Trials in Progress Title: COMPETE Phase III Trial Peptide Receptor Radionuclide Therapy (PRRT) with

Wema Bank hosts webinar to mark IWD 2021

Lagos, Nigeria, March 11, 2021: Nigeria’s leading innovative bank, Wema Bank Plc., through its female proposition, Sara by Wema will mark this year’s International Women’s Day (IWD) with a webinar on Friday, March 12 by 10.00 am. The 90 minutes’ event themed ‘Challenge Today for an Equal Tomorrow’ will have key industry experts and leading female corporate policy influencers in the Nigerian financial, investment, talent development and management ecosystem as panelists. The webinar aims at speaking to women on challenging societal norms to reach their full potential in entrepreneurship, the workplace, or personal lives. The Executive Director, Business Support, Wema Bank, Folake Sanu will host the webinar, while Team Lead, Business Process Re-Engineering, Wema Bank, Chika Adun, will moderate.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.